(+)-Aeroplysinin-1, an antibacterial brominated compound produced by certain sponges, was selected during a blind high-throughput screening for new potential antiangiogenic compounds obtained from marine organisms. In a variety of experimental systems, representing the sequential events of the angiogenic process, aeroplysinin-1 treatment of endothelial cells resulted in strong inhibitory effects. Aeroplysinin-1 inhibited the growth of endothelial cells in culture and induced endothelial cell apoptosis. Capillary tube formation on Matrigel was completely abrogated by addition of aeroplysinin-1 at the low micromolar range. Aeroplysinin-1 also exhibited a clear inhibitory effect on the migration capabilities of endothelial cells. Zymographic assays showed that aeroplysinin-1 treatment produced a decrease in the concentration of matrix metalloproteinase-2 and urokinase in conditioned medium from endothelial cells. Finally, aeroplysinin-1 exhibited a dose-dependent inhibitory effect on the in vivo chorioallantoic membrane assay, showing potent apoptosis-inducing activity in the developing endothelium. The in vivo inhibition of angiogenesis by aeroplysinin-1 was confirmed by the Matrigel plug assay. Together, our data indicate that aeroplysinin-1 is a compound that interferes with key events in angiogenesis, making it a promising drug for further evaluation in the treatment of angiogenesisrelated pathologies.
inhibitors. Since the earliest hypothesis that tumour growth was dependent on angiogenesis (2) , it has become clear that interfering with and /or preventing angiogenesis is an attractive therapeutic approach to the treatment of angiogenesis-dependent diseases (3, 4) .
The development of new blood vessels is a complex multistep process. Endothelial cells resting in the parent vessels are activated by an angiogenic signal and are stimulated to synthesize and release degradative enzymes, which allows endothelial cells to migrate, proliferate, and finally differentiate to give rise to capillary tubules. Any of these steps may be a potential target for pharmacological intervention.
During a blinded screening program of a number of extracts and bioactive compounds isolated from marine organisms, an organic extract from the sponge Aplisina aerophoba was selected by means of its ability to inhibit endothelial cell differentiation in vitro. The compound that was responsible of the detected antiangiogenic activity was isolated and structurally characterized. This compound was identified as (+)-aeroplysinin-1, a naturally occurring brominated tyrosine metabolite ( Fig. 1 ), initially isolated from the marine sponge Verongia aerophoba (5) . This compound has been described to be cytotoxic in vitro to lymphoma, Friend erythroleukemia, and mammary and colon carcinoma cells. Aeroplysinin-1 also displayed in vivo antileukemic activity in the L5178Y cell/NMRI mouse system (6) . A defensive role of this compound for the sponges has been postulated (7).
Here we present results showing that aeroplysinin-1 inhibited the differentiation and proliferation of endothelial cells in vitro, and it induced apoptosis in bovine aortic endothelial (BAE) cells. Aeroplysinin-1 treatment caused a shift of the proteolytic balance of BAE cells toward antiproteolysis, as well as an inhibition of migration and invasion in vitro. In vivo, the antiangiogenic activity of aeroplysinin-1 was shown by the chick chorioallantoic membrane (CAM) and the Matrigel plug assays. Taken together, these data indicate that aeroplysinin-1 inhibits several essential steps of the angiogenic process. This work thus underscores the possibility of utilizing compounds derived from marine organisms as potential new sources of angiogenesis inhibitors that could be used for the treatment of angiogenesis-related malignancies.
MATERIALS AND METHODS

Materials
Cell culture media were purchased from GIBCO (Grand Island, NY) and Biowhittaker (Walkersville, MD). FBS was a product of Harlan-Seralab (Belton, UK). Matrigel was purchased from Becton Dickinson (Bedford, MA), and Calcein-AM was from Molecular Probes (Eugene, OR). Supplements and other chemicals not listed in this section were obtained from Sigma Chemical (St. Louis, MO). Plastics for cell culture were supplied by NUNC (Roskilde, Denmark). (+)-Aeroplysinin-1, isolated and purified from A. aerophoba by Instituto Biomar (León, Spain), was dissolved in dimethyl sufoxide (DMSO) at a concentration of 2 mg/ml and stored at -20ºC until use. Fertilized chick eggs were obtained from Granja Santa Isabel (Córdoba, Spain).
Cell culture
BAE cells were maintained, as previously described, in Dulbecco's modified Eagle's medium containing glucose (1 g/L), glutamine (2 mM), penicillin (50 IU/ml), streptomycin (50 µg/ml), and amphotericin (1.25 µg/ml) (DMEM) supplemented with 10% FBS (DMEM/10% FBS) (8) . Human umbilical vein endothelial (HUVE) cells were isolated from human umbilical cords by collagenase digestion (9) and were maintained in Medium 199 containing 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; 10 mM), L-glutamine (2 mM), heparin (10 mg/ml), penicillin (50 IU/ml), streptomycin (50 µg/ml), and amphotericin (1.25 µg/ml), supplemented with 3 mg/L endothelial cell growth supplement (ECGS, Sigma) and 20% FBS in 5% CO 2 and 37ºC.
Endothelial cell differentiation assay: tube formation on Matrigel
Matrigel (50 µl of about 10.5 mg/ml) at 4ºC was used to coat each well of a 96-well plate and allowed to polymerize at 37ºC for a minimum of 30 min as described previously (10) . Some 5 × 10 4 BAE cells were added with 200 µl of DMEM. For HUVE cells, 2.5 × 10 4 cells were added with 200 µl of Medium 199 supplemented with 5% FBS. Finally, different amounts of aeroplysinin-1 were added and incubated at 37ºC in a humidified chamber with 5% CO 2 . After incubation for 7 or 20 h, cultures were observed (200× magnification) and photographed with a Nikon inverted microscope DIAPHOT-TMD (Nikon, Tokyo, Japan). Each concentration was tested in duplicate, and two different observers evaluated the results of tube formation inhibition.
Cell proliferation assay
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma) dye reduction assay in 96-well microplates was used, essentially as described before (11) . The assay depends on the reduction of MTT by mitochondrial dehydrogenases of viable cells to a blue formazan product, which can be measured spectrophotometrically. BAE cells (either 3 × 10 3 cells in a total volume of 100 µl of DMEM/10% FBS for highly proliferating cells experiments or 3 × 10 4 cells in 100 µl of DMEM supplemented with 2% FBS for low-proliferant cells) were incubated in each well with serial dilutions of aeroplysinin-1. After 3 days of incubation (37 o C, 5% CO 2 in a humid atmosphere), 10 µl of MTT (5 mg/ml in PBS) was added to each well, and the plate was incubated for a further 4 h (37 o C). The resulting formazan was dissolved in 150 µl of 2-propanol containing 0.04 N HCl and was read at 550 nm. All determinations were carried out in quadruplicate. The inhibitory concentration of 50% (IC 50 ) was calculated as the concentration of drug yielding 50% of cell survival.
Cell viability assay
For checking the viability of endothelial cells after the treatment with aeroplysinin-1 in the differentiation assay, BAE or HUVE cells were incubated in a 96-well plate with aeroplysinin-1 in the same conditions employed for the tube formation assay. After 7 or 20 h, cell viability (a comparison with control untreated cells) was determined by the addition of MTT, essentially as described for the cell proliferation assay.
Microscopic images of cells
Untreated and treated BAE cells (3 µM aeroplysinin-1 maintained for 24 h under a humidified, 5% CO 2 atmosphere) were photographed under phase contrast in a Nikon DIAPHOT-TMD microscope.
TUNEL assay in BAE cells
BAE cells were grown to 75% confluency on 8-well Falcon culture slides and incubated for 14 h with or without 3 µM aeroplysinin-1. The TUNEL (terminal deoxynucleotidyl transferasemediated dUTP-biotin nick end-labeling) assay was performed with the use of the In Situ Cell Death Detection Kit (Roche Diagnostics, Barcelona, Spain), according to the manufacturer's instructions.
Conditioned media and cell lysates
To prepare conditioned media and cell lysates, BAE cells were grown in 6-well plates. When the cells were at 75% confluency, medium was aspirated, cells were washed twice with PBS, and each well received 1.5 ml of DMEM/0.1% bovine serum albumin (BSA) containing 200 kIU of aprotinin/ml. In addition, some wells received aeroplysinin-1 (3 µM). After 24 h of incubation, conditioned media were collected. The cells were washed twice with PBS and were harvested by scraping into 0.5 ml of 0.2% Triton X-100 in 0.1 M Tris-HCl containing 200 kIU of Trasylol/ml. Media and cell lysates were centrifuged at 1000g and 4ºC for 20 min. Afterward, the supernatants were collected and used for zymography. Duplicates were used to determine cell number by using a Coulter counter.
Zymographic studies for plasminogen activator and plasminogen activator inhibitor activities
Assays of plasminogen activator (PA) and plasminogen activator inhibitor (PAI) activities in gel were carried out as previously explained (12) . Aliquots of conditioned media and cell lysates normalized for equal cell numbers were subjected to sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) at 4°C under nonreducing conditions, with 3% stacking gel and 10% resolving gel. Gels were washed for 10 min twice with 50 mM Tris-HCl, pH 7.4, supplemented with 2% Triton X-100 and twice with 50 mM Tris-HCl, pH 7.4, and were laid over a substrate gel prepared with agar (0.8%), plasminogen (40 µg/ml), and skim milk (1.5% in PBS). Gels were incubated under a moist atmosphere overnight at 4°C, and afterward they were incubated at 37°C. After 4-8 h, bands of proteolysis caused by PA activity were photographed under dark-field illumination. After an additional day of incubation at room temperature, the only white areas under dark-field illumination (caused by the presence of milk proteins) were those corresponding to bands protected against proteolytic activity, and they represented the bands of PAI activity.
Gelatinolytic assays
The gelatinolytic activity of matrix metalloproteinase-2 (MMP-2) delivered to the conditioned media or present in cell lysates was detected in gelatinograms as previously described (13) . Samples were subjected to nonreducing SDS-PAGE as above but with gelatin (1 mg/ml) added to the 10% resolving gel. After electrophoresis, gels were washed twice with 50 mM Tris-HCl, pH 7.4, supplemented with 2% Triton X-100, and twice with 50 mM Tris-HCl, pH 7.4. Each wash was for 10 min and with continuous shaking. After the washes, the gels, immersed in a substrate buffer (50 mM Tris-HCl, pH 7.4, supplemented with 1% Triton X-100, 5 mM CaCl 2 , and 0.02% Na 3 N), were incubated overnight at 37°C. Then the gels were stained with Coomassie brilliant blue R-250, and the bands of gelatinase activity could be detected as nonstained bands in a dark, stained background.
Quantitative analysis of zymograms and gelatinograms was performed with the NIH Image 1.6 Program.
Endothelial cell migration assay
Migration of fluorescence-labeled endothelial cells was assayed by using a 24-well fluorescenceopaque membrane insert as previously described (14) . This assay allows monitoring of the process in real time, because it eliminates the need to remove nonmigratory cells before quantification of migratory cells. BAE cells were grown to 80-90% confluence in DMEM/10% FBS and then were labeled in situ with 5 µg/ml Calcein-AM in complete culture medium for 2 h at 37ºC. After the cell monolayer was washed, it was briefly trypsinized to lift the cells, which were washed and suspended in DMEM supplemented with 0.1% BSA (DMEM/0.1% BSA). BAE cells were added to 8 µm FALCON HTS FluoroBlok inserts (Becton Dickinson) at a density of 5 × 10 4 cells/insert in the absence or the presence of the indicated concentrations of aeroplysinin-1. DMEM/10% FBS was used as a chemoattractant in the lower wells. The inserts were incubated at 37ºC, and the realtime kinetics of cell migration was determined by taking readings at the indicated time points. Fluorescence of cells that had migrated through the inserts was measured via the Fluorescence Microplate Reader (FL600FA, BIO-TEK Instruments, Winooski, VT) in the bottom-read mode, with excitation/emission wavelengths of 485/530 nm and a gain setting of 75. The number of cells that migrated through the insert was calculated by interpolation via a standard curve comparing relative fluorescence units with the cell number.
Standard curve determination
Calcein-AM BAE cells were diluted in DMEM/BSA to give the indicated cell density per well. The cells were placed in 96-well assay plates and were quantified in the Fluorescence Microplate Reader as described above.
Matrigel invasion assay
The invasion of BAE cells through basement membrane Matrigel was performed as previously described (15, 16) . The quantitation of this assay was simplified by using the 24-well fluorescence-opaque membrane insert employed in migration assay. In this case, filters were coated with Matrigel (25 µg/filter) essentially as described before (17) . BAE cells were labeled with Calcein-AM as described above, suspended in DMEM/0.1% BSA, and added to 8 µm FALCON HTS FluoroBlok inserts at a density of 2 × 10 5 cells/insert in the absence or presence of the indicated concentrations of aeroplysinin-1. DMEM/10% FBS was used as a chemoattractant in the lower wells. The inserts were incubated at 37ºC in 5% CO 2 for 4 h. At the end of incubation, fluorescence of cells that had migrated through the inserts was measured, and the number of invading cells was calculated as described for the migration assay.
CAM assay
The CAM assay was performed essentially as described earlier (18) . Fertilized chick eggs were incubated horizontally at 38ºC in a humidified incubator, windowed by day 3 of incubation and processed by day 8. Aeroplysinin-1 stock solution was added to a 0.7% solution of methylcellulose in water, and 10-µl drops of this solution were allowed to dry on a Teflon-coated surface in a laminar flow hood. Then, the methylcellulose disks were implanted on the CAM, and the eggs were sealed with adhesive tape and returned to the incubator for 48 h. Negative controls were always made with DMSO mixed with the methylcellulose. After the reincubation, the CAM was examined under a stereomicroscope. The assay was scored as positive when two independent observers reported a significant reduction in vascular density in the treated area. Some CAMs were fixed in 4% paraformaldehyde solution in PBS for 2 h, dehydrated in an ethanolic series, and embedded in paraffin.
To check the specific effects of aeroplysinin-1 on the CAM endothelial cells and their progenitors, we modified the assay by using eggs from japanese quails (Coturnix coturnix japonica). Hemangioblasts and endothelial cells of this species can easily be stained with the monoclonal antibody QH1 (19) . The assay was performed as described above with a dose of 6 nmol aeroplysinin-1. Quail CAMs were fixed and embedded as described above.
TUNEL assay in CAM
Apoptosis in the aeroplysinin-1 treated-CAMs was assessed by the above-mentioned TUNEL assay. In brief, paraformaldehyde-fixed, 10-µm paraffin sections were dewaxed, rehydrated, in an ethanolic series, and incubated with proteinase K (20 µg/ml in 10 mM Tris-HCl, pH 7.4) for 15-30 min at 37ºC. They were then rinsed with PBS, and endogenous peroxidase was blocked by incubation for 30 min with 3% hydrogen peroxide in PBS. After the sections were washed, the TUNEL reaction mixture was added, and the sections were incubated at 37ºC for 1 h. When a simultaneous immunostaining of the sections was performed, sections were washed and incubated with the QH1 monoclonal antibody, washed again, and incubated with biotinconjugated anti-mouse IgG (1:100, 1 h) and with extravidin-conjugated tetramethylrhodamine-5-isothiocyanate (1:150, 1 h). The sections, washed and mounted with 1:1 glycerin-PBS, were observed in a confocal microscope. Other sections were incubated, for signal conversion, with an antifluorescein antibody conjugated with peroxidase (37ºC, 30 min), washed, and developed with the diaminobenzidine (DAB) substrate solution.
Matrigel plug assay
The Matrigel plug assay was performed according to the method of Passaniti et al. (20) . Recombinant basic fibroblast growth factor (bFGF) (human sequence) was added to liquid Matrigel kept on ice to attain a concentration of 1 µg/ml. Aeroplysinin-1 stock solution was mixed with the Matrigel to a final concentration of 50 µM. The mixture was injected subcutaneously into C57/BL mice near the abdominal midline, via a 21-gauge needle. About 300 µl of Matrigel, containing 15 nmol of aeroplysinin-1 and 300 ng of bFGF, was injected into each mouse. Control mice received the same volume of Matrigel with bFGF mixed with a corresponding amount of DMSO without aeroplysinin-1. After a time period of between 2 and 7 days, Matrigel plugs were removed together with the surrounding tissue, fixed in 4% paraformaldehyde solution in PBS or in methanol-acetone-water (2:2:1) for 4 h, dehydrated in an ethanolic series, and embedded in paraffin. Sections (10 µm thick) were obtained, were dewaxed, and were stained with hematoxylin-eosin or were immunostained.
For immunohistochemistry, paraffin sections were dewaxed, were hydrated in Tris-phosphatebuffered saline (TPBS), and were blocked for endogenous peroxidase activity by incubation for 30 min with 6% hydrogen peroxide in TPBS. Nonspecific binding sites were saturated for 30 min with 16% sheep serum, 1% BSA, and 0.5% Triton X-100 in PBS (SBT) and then with the avidin-biotin blocking kit (Vector, Burlingame, CA). The slides were incubated overnight at 4°C in the primary antibody diluted in SBT. Control slides were incubated in SBT containing noninmune rabbit IgG. After primary antibody incubation, the slides were washed in TPBS (3 × 5 min), were incubated for 1 h at room temperature in biotin-conjugated anti-rabbit, anti-rat, or anti-mouse goat IgG (Sigma) diluted 1:100 in SBT, were washed again, and were incubated for 1 h in avidin-peroxidase complex (Sigma) diluted 1:150 in TPBS. The slides were finally washed (3 × 5 min TPBS), and the peroxidase activity was developed with Sigma Fast 3,3-DAB tablets.
The rabbit polyclonal antibody against the endothelial marker factor VIII-related antigen (Sigma) was used at a 1:800 dilution. The monoclonal anti-proliferating cell nuclear antigen (PCNA) (clone PC10, Sigma) was used at a 1:500 dilution. The monoclonal antibody anti-QH1 antigen was obtained from the Developmental Studies Hybridoma Bank. It was used at a 1:100 dilution in immunofluorescence studies.
Image analysis was performed with hematoxylin-eosin stained sections of Matrigel plugs (six mice treated with aeroplysinin-1 and six controls) according to standard procedures (21) . For each plug of Matrigel, two sections, separated by at least 1 mm, were selected from the central part. The identity of the sections as experimental or control was encoded and thus unknown to the analyzer. One area of about 1.5 mm 2 of each section was randomly chosen and digitalized with a Nikon Coolpix digital camera. The digitalized images (1600 × 1200 pixels) were processed with the Scion Image Analysis software. First, stained cells were manually discriminated from the background by using a density slicing procedure and were converted to a binary map. Isolated pixels were removed, and the profiles were smoothed with an "open" operation. One area of the Matrigel plug, between 0.6 and 0.9 mm 2 was selected, excluding the surface. In this area, three parameters were automatically measured, namely, the percentage of the area covered by cells, the number of individual particles (i.e., cells or cell groups), and the spatial scattering of the cells throughout the surface of the Matrigel section. The last parameter was assessed by superposing the binary image to a image composed of points with a density of 800 points/mm 2 . The number of intersections between both images was automatically counted. Images of immunostained sections were analyzed in the same way.
Statistical analysis
All data are expressed as means + standard deviation (SD). One-tailed Student's t test was used for evaluations of pairs of means, to establish which groups differed from the control group. P < 0.05 was considered to be statistically significant.
RESULTS
Aeroplysinin-1 inhibits the capillary tube formation by endothelial cells
Initially, the compounds isolated during our screening program were tested for their ability to inhibit the endothelial cell differentiation in vitro with the above-described microplate assay. From this primary screening, aeroplysinin-1 was chosen to be further characterized for its antiangiogenic activity.
The final event during angiogenesis is the organization of endothelial cells in a 3-D network of tubes. In vitro, endothelial cells plated on Matrigel aligned themselves to form cords, which were already evident a few hours after plating (Fig. 2) . The addition of aeroplysinin-1 (0.7 µM) to the assay resulted in complete inhibition of BAE cell alignment and cord formation. When HUVE cells were used in the tube formation assay, 3 µM aeroplysinin-1 completely inhibited their in vitro differentiation on Matrigel (Fig. 2) .
The treatment with aeroplysinin-1, at the concentrations used to inhibit the differentiation of BAE or HUVE cells, did not affect the viability of those endothelial cells after 7 or 20 h (results not shown).
Aeroplysinin-1 inhibits the growth of endothelial cells
Angiogenesis involves local proliferation of endothelial cells. We investigated the ability of aeroplysinin-1 to inhibit the proliferation of actively growing endothelial cells. As shown in Fig.  3 , aeroplysinin-1 inhibited, in a concentration-dependent manner, the growth of cultured BAE cells. The IC 50 value of this antiproliferative effect was 2.1 + 0.2 µM (mean of three different experiments + SD) for subconfluent BAE cells stimulated to grow with 10% FBS. The activity of this compound decreased when low-proliferant endothelial cells were used (Fig. 3) . In highdensity, low-proliferant BAE cells, the IC 50 value for aeroplysinin-1 significantly increased to 7.30 + 3.2 µM (mean of three different experiments + SD) (P<0.05).
Aeroplysinin-1 induces morphological changes and apoptosis in BAE cells
As Fig. 4 shows, 3 µM aeroplysinin-1 induced drastic morphological changes in BAE cells growing in culture after 24 h of treatment. Figure 5 shows that apoptosis was also induced in BAE cells by treatment with aeroplysinin-1 (3 µM) for 14 h, as determined by TUNEL staining.
Aeroplysinin-1 induces a shift in the proteolytic balance toward antiproteolysis
Angiogenesis involves the acquisition by endothelial cells of the capability to degrade the basement membrane and, in general, to remodel the extracellular matrix. Gelatin zymography of conditioned media and cell extracts of BAE cells untreated or treated for 24 h with 3 µM aeroplysinin-1 (Fig. 6) showed that although extracts of treated cells contained higher amounts of MMP-2, the concentration of MMP-2 in the medium conditioned by aeroplysinin-treated cells was clearly lower than that in untreated cell medium. Quantitave analyses showed that MMP-2 bands in aeroplysinin-treated cell conditioned media were 60 + 4% those of untreated cells, whereas extracts of treated cells yielded MMP-2 bands that were almost twofold (1.77 + 0.04) those of untreated cells (mean of three experiments + SD). Thus, aeroplysinin-1 seems to affect mainly the release of MMP-2 to the medium.
The other system involved in extracellular matrix remodeling is that of PA/PAI. As Fig. 6 shows, aeroplysinin-1 treatment induced an important decrease in the expression of PA protein and a parallel increase in the expression of PAI protein in both conditioned media and cell extracts. It is noteworthy that, in contrast with our observation for MMP-2, the PA band decreased and the PAI band increased in both conditioned media and cell extracts of treated cells. In fact, PA bands from conditioned media of treated cells decreased to 16 + 0% of controls (mean of two experiments + SD), and those from cell extracts decreased to 51 + 3% of control values (mean of three experiments + SD). Furthermore, PAI bands in conditioned media and cell extracts of aeroplisinin-treated cells were 1.6-fold (1.62 + 0.25) and more than 4-fold (4.43 + 2.45) greater than those of controls (mean of two experiments + SD).
Aeroplysinin-1 inhibits migration and invasion of BAE cells
The effects of aeroplysinin-1 on migration and invasion of fluorescence-labeled BAE cells through Matrigel-coated filters were investigated. As shown in Fig. 7 , aeroplysinin-1 inhibited both processes in a dose-dependent manner: 1.5 µM aeroplysinin-1 completely abolished migration of BAE cells in this modified Boyden chamber assay (Fig. 7A) . No effect of aeroplysinin-1 on migration of BAE cells was observed when the compound was added to the lower well (results not shown).
The presence of 3 µM aeroplysinin-1 during the chemoinvasion assay resulted in a 50% inhibition of the ability of BAE cells to invade through Matrigel-coated filters (Fig. 7B) .
Aeroplysinin-1 inhibits angiogenesis and induces apoptosis in the CAM
The CAM assay was used to determine the ability of aeroplysinin-1 to inhibit angiogenesis in vivo (22, 23) . In controls, blood vessels formed a dense and spatially oriented, leaf-like branching network composed of vascular structures of progressively smaller diameter as they branch. Treatment with aeroplysinin-1 caused a dose-dependent antiangiogenic effect, with 27% of treated eggs scored as positive at 1.5 nmol, and had a maximum effect at 3 nmol, when 100% of the eggs were scored as positive (Table 1) .
Treatment with aeroplysinin-1 at doses of 6 and 15 nmol produced a severe disorganization of the preexisting vessels and a complete inhibition of the ingrowth of new vessels in the area covered by the methylcellulose disks (Fig. 8A, B) . The effects were already visible after 60 min of treatment, when the vessels became leaky and blood started to extravasate. This effect provoked an intratissue hemorrhage that always appeared in the treated area. After 48 h, the treated area was completely avascular; peripheral vessels avoided the treated area. The lack of functional vessels was confirmed in the histological sections. Signs of irritation or inflammation, such as a whitening of the CAM, were not observed.
Aeroplysinin-1 had potent apoptotic activity in the CAM membrane, as shown by the TUNEL assay (Fig. 8C, D) . Apoptosis was detectable 19 h after the treatment, and the effect was much stronger than the effect caused by similar doses of the positive control camptothecin (data not shown). The apoptotic cells were mainly located in the areas of vascular differentiation (i.e., the chorioallantoic surface) and in the walls of the large vessels (Fig. 8D) . The effect on the the endothelium and blood islands filled with immature blood cells was particularly intense, as shown by QH1 plus TUNEL double labeling of the quail CAMs (Fig. 8E ). Other cells, such as fibroblasts and endodermal allantoic cells, remained largely unaffected by the treatment.
Aeroplysinin-1 inhibits angiogenesis in the Matrigel plug assay
In the Matrigel assay, aeroplysinin-1 caused a strong inhibition of cell invasion (Fig. 9) . All the parameters assessed, i.e., the percentage of surface covered and the number and scattering of particles, were significantly different between control and aeroplysinin-treated Matrigel plugs, with an average reduction of about 70% (Fig. 9) . The difference was especially remarkable in the number of particles and in their spreading throughout the plug volume, as shown by the number of intersections of the binarized image with a random array of points. The density of factor VIII-related antigen-immunoreactive vessels and the number of proliferating cells (assessed by PCNA staining) was highly reduced in the aeroplysinin-treated Matrigel plugs in relation to the controls. The average reduction was about 90% as assessed by image analysis (Fig. 9) . Peripheral areas surrounding the Matrigel plug showed abundant PCNApositive cells in control as well as in experimental mice.
DISCUSSION
Knowledge related to the sequence of events required for neovascularization and the availability of cultured endothelial cells have allowed for the development and use of in vitro assays to expedite the discovery of angiogenesis inhibitors. These inhibitors could block any of the following components of the angiogenic process: degradation of the basement membrane, migration and proliferation of endothelial cells, and formation of capillary-like tubes. A factor that could inhibit one or several of these key events in vitro is a candidate for the inhibition of angiogenesis in vivo (24).
Our results demonstrate for the first time that aeroplysinin-1 inhibited certain functions of endothelial cells, namely, differentiation, proliferation, migration, and invasion through basement membrane Matrigel in vitro, as well as angiogenesis in vivo. These effects were dose dependent and were obtained at doses that were lower than those required by other previously described inhibitors of angiogenesis.
Antiangiogenic activity of aeroplysinin-1 was first detected by using the in vitro differentiation assay for endothelial cells. Our results showed that aeroplysinin-1 inhibited capillary-like tube formation by BAE or HUVE cells. The effective concentration was 0.7 µM for BAE cells, which was lower than the concentration required to inhibit BAE cell proliferation (IC 50 = 2.1 µM). This suggests that the antiangiogenic activity of aeroplysinin-1 depended on the prevention of capillary-like tube formation rather than proliferation. This inhibitory effect of aeroplysinin-1 on the morphogenesis of endothelial tubes is not due to cytotoxicity and is exerted at concentrations that are lower than those required for other known inhibitors (25) (26) (27) .
Capillary endothelial cells proliferate in response to an angiogenic stimulus during neovascularization. We showed that aeroplysinin-1 inhibited the growth of highly proliferant BAE cells more efficiently than did other previously described inhibitors of angiogenesis (27) (28) (29) . Aeroplysinin-1 exhibited a significantly lower activity on low-proliferant BAE cells, which suggests the possibility that aeroplysinin treatment could affect mainly newly formed rather than preexisting blood vessels.
The cytotoxic effect of 3 µM aeroplysinin-1, as evidenced by changes in cell morphology, was already seen after 24 h of treatment. The results here obtained using the TUNEL assay with aeroplysinin-treated BAE cells show that the cytotoxic effect produced by 3 µM aeroplysinin-1 on proliferant endothelial cells could be due, at least in part, to an induction of apoptosis. Likewise, it was previously reported that a number of endogenous and exogenous angiogenesis inhibitors do induce endothelial cell apoptosis (30, 31) . It has been suggested that endothelial cell apoptosis induced by a variety of mechanisms might be responsible for inhibiting angiogenesis, thereby preventing the growth of primary tumors and their metastases. Although in our hands this has not been the most prominent effect of aeroplysinin-1 on endothelial cells, its contribution to the antiangiogenic potential role of aeroplysinin-1 cannot be ruled out.
A net positive proteolytic balance is required for capillary sprout elongation and lumen formation during angiogenesis. Matrix metalloproteinases and serine proteinases have been postulated to play a key role in angiogenesis (32) . MMP-2 has been shown to modulate the morphology of endothelial structures, as well as their invasive behavior in in vitro and in vivo assay systems (33, 34) . Pepper et al. (35) showed that agents that induce angiogenesis such as bFGF induce urinary PA (uPA) as well as PAI-1; however, the ratio of the levels of uPA and PAI-1 mRNA induced by angiogenic factors is tilted toward enhanced proteolysis. The proteolytic balance can be modulated by some inhibitors of angiogenesis (36, 37) . BAE cells in culture produced MMP-2, PA, and PAI as detected by zymographic techniques (Fig. 6 ). Incubation with 3 µM aeroplysinin-1 caused a decrease in the MMP-2 secreted to medium by endothelial cells, the total MMP-2 produced by BAE cells remaining unchanged. Similar decreases in MMP-2 activity in the conditioned media of endothelial cells have been described for curcumin (26) and halofuginone (16), two recently described inhibitors of angiogenesis, and they have been suggested to lead to the inhibition of endothelial cell tube formation in vitro. PA produced by aeroplysinin-1-treated cells significantly decreased compared with control cells, whereas PAI levels increased (Fig. 6) . Taken together, these data seem to indicate that aeroplysinin-1 causes a shift toward antiproteolysis in BAE cells. This result agrees with the observed inhibition of migration and invasive ability of the aeroplysinin-treated endothelial cells (Fig. 7) . In response to angiogenic stimuli, endothelial cells migrate from the vascular wall and invade the connective tissue and parenchyma. Agents as aeroplysinin-1, which suppress endothelial cell migration, are potential inhibitors of neovascularization.
Inhibition by aeroplysinin-1 of the above-mentioned essential steps of in vitro angiogenesis agrees well with the effect on in vivo angiogenesis that we observed. Our results show that aeroplysinin-1 was active in the CAM assay at concentrations that were lower than those required for other described inhibitors of angiogenesis (27, 28, 38) . We also observed that aeroplysinin-1 produced a devastating effect on the developing vessels of the CAM, probably because of induction of apoptosis in the vascular cells and their progenitors. An additional effect that was found in the CAM was the generation of hemorrhages. This was probably due to the fast disorganization and the loss of integrity of the vascular wall in the preexisting vessels, as revealed by direct observation. In contrast, aeroplysinin provoked an inhibition of the bFGFmediated cell invasion in the intradermal Matrigel plug model. The inhibition was not complete, however, and a number of cells were found within the aeroplysinin-treated Matrigel. However, unlike the controls, the invading cells rarely showed factor VIII-related antigen, a differentiation marker of the endothelial cells. A possible explanation is that aeroplysinin-1 specifically blocked the migration and/or the differentiation of endothelial cells within the Matrigel, as we observed in the in vitro assays. Finally, the proliferation marker PCNA was also rarely found in the cells within the experimental Matrigel in contrast to the large number of PCNA-positive cells observed in control plugs, indicating that aeroplysinin-1 either inhibited proliferation of the cells that invaded the Matrigel or stopped proliferating cells from invading the plug.
The pleiotropic nature of the activity of aeroplysinin-1 on endothelial cells in vitro resembles that of some receptor tyrosine kinase inhibitors (39) . Aeroplysinin-1 inhibits the epidermal growth factor receptor (EGFR) tyrosine kinase in an in vitro test system (40) . Nevertheless, the ability of this compound to inhibit EGFR or platelet-derived growth factor receptor in vivo has been questioned (41) . No data regarding the effect of aeroplysinin-1 on other receptors such as those for bFGF, vascular endothelial growth factor (VEGF), or angiopoietin, which play a main role in the angiogenic process, have been published so far. We think that a putative inhibition of the receptors tyrosine kinases by aeroplysinin-1 could account for the observed antiangiogenic activity. Receptor tyrosine kinases are critically involved not only in the proliferation of endothelial cells, but also in their differentiation and survival, and for that reason they play a key role in angiogenesis (42) . Endothelial cells are protected from apoptosis by at least three growth factors whose high-affinity receptors are tyrosine kinases, namely, bFGF, VEGF, and angiopoietin-1. In vitro, bFGF protects endothelial cells from apoptosis and induces tube formation in a collagen gel model (43) . Blockade of bFGF through antibodies is enough to inhibit angiogenesis in CAM (44) . However, the VEGFR-2 (Flk-1/KDR) and the Tie-2 angiopoietin receptor are essential for the survival and growth of endothelial cells (45) (46) (47) . These growth factors induce phosphorylation of the Akt/protein kinase B in a signal transduction pathway crucial for the survival of the endothelial cells. Through this pathway, VEGF and angiopoietin-1 up-regulate the production of the apoptosis inhibitor survivin (48, 49) . We suggest that one or several of these tyrosine kinase receptors could be blocked by aeroplysinin-1, thus inhibiting the transduction of survival signals. This effect should be more dramatic in proliferating endothelial cells, such as those from the CAM, because survivin is minimally conducted by using a 24-well fluorescence-opaque membrane insert and BAE cells that had been previously labeled with Calcein-AM . A) Migration assay: 5 × 10 4 fluorescence-labeled BAE cells suspended in DMEM/0.1% BSA were seeded in the upper wells, without aeroplysinin-1 (•) or in the presence of 0.75 µM (▲) or 1.5 µM ( ) aeroplysinin-1. DMEM /10% FBS was used as a chemoattractant in the lower wells. The inserts were incubated at 37ºC, and cell migration was determined by taking readings at the indicated time points. B) Invasion assay: 2 × 10 5 fluorescence-labeled BAE cells suspended in DMEM/0.1% BSA were incubated (4 h, 37ºC) on top of Matrigel-coated filters, without aeroplysinin-1 (control) or in the presence of the indicated concentrations of aeroplysinin-1. DMEM/10% FBS was used as a chemoattractant in the lower wells. The number of cells that had migrated or invaded through the filter was determined as indicated in Materials and Methods. The results are the means ± SD of triplicate filters. Statistically significant differences between aeroplysinin-treated cells and their respective untreated control cells are indicated by a: P < 0.05, b: P < 0.01, and c: P < 0.005. 2 , and the scattering of the particles, measured by the number of intersections between the binarized image and a random array of points, showed an average reduction of about 70% (n = 12) after aeroplysinin-1 treatment. The percentage of the Matrigel area covered by factor VIII-related antigen-positive cells and the number of immunoreactive particles per mm 2 showed an average reduction of about 90% for the aeroplysinin-1-containing Matrigel compared with the controls (n = 4). A similar reduction was found in the number of PCNA-positive cells (n = 4). All differences were significant (**P<0.01).
